These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 35300966)

  • 1. Implications of ligand-receptor binding kinetics on GLP-1R signalling.
    Zhao P; Truong TT; Merlin J; Sexton PM; Wootten D
    Biochem Pharmacol; 2022 May; 199():114985. PubMed ID: 35300966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural Mapping and Functional Characterization of Zebrafish Class B G-Protein Coupled Receptor (GPCR) with Dual Ligand Selectivity towards GLP-1 and Glucagon.
    Oren DA; Wei Y; Skrabanek L; Chow BK; Mommsen T; Mojsov S
    PLoS One; 2016; 11(12):e0167718. PubMed ID: 27930690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The GIP receptor displays higher basal activity than the GLP-1 receptor but does not recruit GRK2 or arrestin3 effectively.
    Al-Sabah S; Al-Fulaij M; Shaaban G; Ahmed HA; Mann RJ; Donnelly D; Bünemann M; Krasel C
    PLoS One; 2014; 9(9):e106890. PubMed ID: 25191754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computational modelling of dynamic cAMP responses to GPCR agonists for exploration of GLP-1R ligand effects in pancreatic β-cells and neurons.
    Bridge L; Chen S; Jones B
    Cell Signal; 2024 Jul; 119():111153. PubMed ID: 38556030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional consequences of glucagon-like peptide-1 receptor cross-talk and trafficking.
    Roed SN; Nøhr AC; Wismann P; Iversen H; Bräuner-Osborne H; Knudsen SM; Waldhoer M
    J Biol Chem; 2015 Jan; 290(2):1233-43. PubMed ID: 25451942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamics of GLP-1R peptide agonist engagement are correlated with kinetics of G protein activation.
    Deganutti G; Liang YL; Zhang X; Khoshouei M; Clydesdale L; Belousoff MJ; Venugopal H; Truong TT; Glukhova A; Keller AN; Gregory KJ; Leach K; Christopoulos A; Danev R; Reynolds CA; Zhao P; Sexton PM; Wootten D
    Nat Commun; 2022 Jan; 13(1):92. PubMed ID: 35013280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The complexity of signalling mediated by the glucagon-like peptide-1 receptor.
    Fletcher MM; Halls ML; Christopoulos A; Sexton PM; Wootten D
    Biochem Soc Trans; 2016 Apr; 44(2):582-8. PubMed ID: 27068973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Second extracellular loop of human glucagon-like peptide-1 receptor (GLP-1R) has a critical role in GLP-1 peptide binding and receptor activation.
    Koole C; Wootten D; Simms J; Miller LJ; Christopoulos A; Sexton PM
    J Biol Chem; 2012 Feb; 287(6):3642-58. PubMed ID: 22147710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential GLP-1R Binding and Activation by Peptide and Non-peptide Agonists.
    Zhang X; Belousoff MJ; Zhao P; Kooistra AJ; Truong TT; Ang SY; Underwood CR; Egebjerg T; Šenel P; Stewart GD; Liang YL; Glukhova A; Venugopal H; Christopoulos A; Furness SGB; Miller LJ; Reedtz-Runge S; Langmead CJ; Gloriam DE; Danev R; Sexton PM; Wootten D
    Mol Cell; 2020 Nov; 80(3):485-500.e7. PubMed ID: 33027691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Characterisation of Small Molecule Agonists Effect on the Human Glucagon Like Peptide-1 Receptor Internalisation.
    Thompson A; Stephens JW; Bain SC; Kanamarlapudi V
    PLoS One; 2016; 11(4):e0154229. PubMed ID: 27100083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Interplay of Glucagon-Like Peptide-1 Receptor Trafficking and Signalling in Pancreatic Beta Cells.
    Marzook A; Tomas A; Jones B
    Front Endocrinol (Lausanne); 2021; 12():678055. PubMed ID: 34040588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonconventional glucagon and GLP-1 receptor agonist and antagonist interplay at the GLP-1 receptor revealed in high-throughput FRET assays for cAMP.
    Chepurny OG; Matsoukas MT; Liapakis G; Leech CA; Milliken BT; Doyle RP; Holz GG
    J Biol Chem; 2019 Mar; 294(10):3514-3531. PubMed ID: 30622136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The G Protein-First Mechanism for Activation of the Class B Glucagon-like Peptide 1 Receptor Coupled to N-Terminal Domain-Mediated Conformational Progression.
    Li B; Yang MY; Kim SK; Goddard WA
    J Am Chem Soc; 2024 Sep; 146(38):26251-26260. PubMed ID: 39266057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential Requirement of the Extracellular Domain in Activation of Class B G Protein-coupled Receptors.
    Zhao LH; Yin Y; Yang D; Liu B; Hou L; Wang X; Pal K; Jiang Y; Feng Y; Cai X; Dai A; Liu M; Wang MW; Melcher K; Xu HE
    J Biol Chem; 2016 Jul; 291(29):15119-30. PubMed ID: 27226600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural Determinants of Binding the Seven-transmembrane Domain of the Glucagon-like Peptide-1 Receptor (GLP-1R).
    Yang D; de Graaf C; Yang L; Song G; Dai A; Cai X; Feng Y; Reedtz-Runge S; Hanson MA; Yang H; Jiang H; Stevens RC; Wang MW
    J Biol Chem; 2016 Jun; 291(25):12991-3004. PubMed ID: 27059958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of biased agonism mediated by dual agonists of the GLP-1 and glucagon receptors.
    Darbalaei S; Yuliantie E; Dai A; Chang R; Zhao P; Yang D; Wang MW; Sexton PM; Wootten D
    Biochem Pharmacol; 2020 Oct; 180():114150. PubMed ID: 32682761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucagon-like peptide-1 receptor ligand interactions: structural cross talk between ligands and the extracellular domain.
    West GM; Willard FS; Sloop KW; Showalter AD; Pascal BD; Griffin PR
    PLoS One; 2014; 9(9):e105683. PubMed ID: 25180755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and preparation of the class B G protein-coupled receptors GLP-1R and GCGR for
    Wang H; Hu W; Liu D; Wüthrich K
    FEBS J; 2021 Jul; 288(13):4053-4063. PubMed ID: 33369025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetically encoded photocross-linkers determine the biological binding site of exendin-4 peptide in the N-terminal domain of the intact human glucagon-like peptide-1 receptor (GLP-1R).
    Koole C; Reynolds CA; Mobarec JC; Hick C; Sexton PM; Sakmar TP
    J Biol Chem; 2017 Apr; 292(17):7131-7144. PubMed ID: 28283573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthetic protease-activated class B GPCRs.
    Willard FS; Meredith TD; Showalter AD; Ma W; Ho JD; Sauder JM; Sloop KW
    Biochem Biophys Res Commun; 2020 Sep; 530(1):246-251. PubMed ID: 32828294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.